Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Anxiety in Advanced-Stage Cancer
NCT00302744Phase 2Completed
- Sponsor
- The Lundquist Institute
- Start
- Apr 2004
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anxiety disorder comparing Psilocybin with Active Niacin Placebo (2 arms). Primary endpoint: Anxiety at 6 months. Started Apr 2004; status: completed.
02
Drugs
psilocybin
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT00302744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302744.